Study of Liposomal Annamycin in Combination With Cytarabine for the Treatment of Subjects With Acute Myeloid Leukemia (AML)
Clinical trial NCT05319587 · COMPLETED
Trial details
- NCT number
- NCT05319587
- Sponsor
- Moleculin Biotech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-29
- Primary completion
- 2023-08-02
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.